Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with ...
Vesalius Will Apply its Proprietary Platform to Identify Novel Intervention Points that GSK may Advance for the Treatment of Patients with Parkinson's Disease GSK has Licensed a Preclinical Small Molecule Inhibitor Program CAMBRIDGE, Mass., Nov. 12, …